Table 2 Univariate and multivariate analysis for prognostic factors in patients with peritoneal metastasis.
Variable | Number | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |||
Age, years | > 70/≦70 | 20/40 | 1.824 | 1.329–5.309 | 0.037 | 1.741 | 0.661–2.573 | 0.09 |
Sex | Male/female | 26/34 | 1.204 | 0.712–2.037 | 0.4826 | |||
Performance status | 0 /1, 2 | 50/10 | 2.471 | 0.945–6.457 | 0.0059 | 0.794 | 0.323–1.955 | 0.616 |
BMI | ≦ 19.8/>19.8 | 30/30 | 0.949 | 0.561–1.604 | 0.8387 | |||
Histology (Nakamura’s classification) | Differentiated/undifferentiated | 13/47 | 0.908 | 0.480–1.717 | 0.7509 | |||
Histology (Lauren’s classification) | Intestinal/diffuse and mixed | 10/50 | 0.798 | 0.421–2.053 | 0.594 | |||
first-onset case/recurrent case | first-onset /recurrence case | 53/7 | 0.961 | 0.440–2.097 | 0.9211 | |||
Size of PM | Bowel resection/biopsy or excision alone | 17/43 | 1.067 | 0.608–1.873 | 0.8204 | |||
Location of resected PM | Visceral peritoneum/parietal peritoneum | 47/13 | 1.150 | 0.603–2.191 | 0.6561 | |||
Chemotherapy | Yes/no | 57/3 | 0.084 | 0.002–3.808 | < 0.001 | 0.158 | 0.034–0.738 | 0.019 |
Intraperitoneal chemotherapy | Yes/no | 32/28 | 0.809 | 0.473–1.382 | 0.4147 | |||
P stage | P1a/P1b, P1c | 9/51 | 1.399 | 0.693–2.826 | 0.3972 | |||
CEA | >5/≦5 | 13/47 | 1.974 | 0.913–4.272 | 0.026 | 0.971 | 0.436–2.165 | 0.943 |
CA19-9 | >37/≦37 | 14/46 | 1.509 | 0.729–3.123 | 0.1932 | |||
CA125 | >35/≦35 | 20/40 | 1.480 | 0.822–2.665 | 0.1494 | |||
Platelet | ≦ 223 × 103/>223 × 103 | 20/40 | 1.734 | 0.916–3.282 | 0.447 | |||
CRP | >1.0/≦1.0 | 9/51 | 1.505 | 0.658–3.444 | 0.250 | |||
PNI | ≦ 40/>40 | 26/34 | 1.185 | 0.695–2.021 | 0.515 | |||
Breg frequency in primary lesion | >10.2/≦10.2 | 27/33 | 1.605 | 0.963–2.675 | 0.068 | |||
Breg frequency in PM | high/low | 29/31 | 2.144 | 1.222–3.763 | 0.002 | 2.314 | 1.298–4.124 | 0.004 |